Talk:Pertuzumab
Appearance
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Pertuzumab.
|
This is the talk page for discussing improvements to the Pertuzumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
APHINITY confirmatory trial
[edit]APHINITY is the confirmatory trial for the September 2013 accelerated approval. Phase III Trial Results Confirm Adjuvant Pertuzumab Success in HER2+ Breast Cancer - Could mention in History or a new Clinical trials section ? - Rod57 (talk) 18:05, 20 March 2017 (UTC)